The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The liraglutide market size has grown strongly in recent years, increasing from $5.87 billion in 2023 to $6.38 billion in 2024, at a compound annual growth rate (CAGR) of 8.6%. This growth in the historic period can be attributed to factors such as the rising number of people diagnosed with type 2 diabetes, escalating obesity rates, extensive clinical trials, growing awareness of diabetes complications, and innovative advancements in drug delivery systems. The liraglutide market size is projected to continue its robust growth, expected to reach $8.90 billion in 2028, with a CAGR of 8.7%. This anticipated growth is driven by factors like improving insurance and reimbursement policies, developing healthcare infrastructure, increasing awareness through educational initiatives, a growing aging population, and the rising prevalence of diabetes. Major trends expected to shape the forecast period include the incorporation of artificial intelligence and machine learning, heightened demand for wearable technology, integration of continuous glucose monitoring, advancements in biotechnology, and the evolution of digital health platforms.

The increasing population of individuals with diabetes is likely to propel the growth of the liraglutide market in the upcoming years. Diabetes, a chronic condition characterized by the body’s inability to effectively regulate blood sugar levels, is on the rise due to sedentary lifestyles, unhealthy diets, and increasing obesity rates globally. Liraglutide, a diabetes medication, mimics the action of the hormone GLP-1, enhancing insulin secretion, lowering blood sugar levels, and promoting weight loss, thereby aiding in managing type 2 diabetes. For instance, in 2021, the International Diabetes Federation (IDF), a Belgium-based non-profit organization, reported that 537 million adults aged 20–79, or 1 in 10, were living with diabetes. This number is projected to rise to 643 million by 2030 and reach 783 million by 2045. Notably, over 75% of adults with diabetes live in low- and middle-income countries. Consequently, the increasing diabetic population is driving the growth of the liraglutide market.

Get A Free Sample On The Liraglutide Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

What Are The Key Trends That Influence Liraglutide Market Share Analysis?
Major companies in the liraglutide market are developing novel products like generic GLP-1 to broaden treatment options and meet the growing demand for more affordable alternatives. Generic GLP-1 refers to versions of GLP-1 receptor agonists produced after the original branded medications’ patent protection expires, offering cost-effective treatments for conditions like type 2 diabetes and obesity. For instance, in June 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, launched the first generic GLP-1 similar to Victoza in the U.S. market, addressing the increasing demand for these therapies. Liraglutide injections are prescribed to improve blood sugar management in adults and children aged 10 and above with type 2 diabetes and to lower the risk of cardiovascular incidents in adults with type 2 diabetes and existing cardiovascular conditions.

Which Market Players Are Driving Growth In The Liraglutide Market?
Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

How Is The Global Liraglutide Market Segmented?
The liraglutide market covered in this report is segmented –
1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings

Read The Full Liraglutide Market Report Here
https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

The Liraglutide Global Market Report 2024 provides an overview of the liraglutidemarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The liraglutide market forecast analyzes liraglutide market size, liraglutide market share, leading competitor and their market positions.

The Table Of Content For The Liraglutide Market Include
1. Liraglutide Market Executive Summary
2. Liraglutide Market Segments
3. Liraglutide Market Size And Template Market Growth Rate
4.  Key Liraglutide Market Trends
5. Major Liraglutide Market Drivers
……
25. Key Mergers And Acquisitions In The Liraglutide Market
26. Top Liraglutide Companies
27. Liraglutide Market Opportunities And Strategies
28. Liraglutide Market, Conclusions And Recommendations
29. Appendix

Explore Similar Reports From The Business Research Company:

Antidiarrheals Market 2024
https://www.thebusinessresearchcompany.com/report/antidiarrheals-global-market-report

Anti-Aging Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anti-aging-global-market-report

Television Network Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/television-network-global-market-report

Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: